NIAB scientists working on next generation vaccine against ‘Leptospirosis’

One million cases of human leptospirosis are reported every year resulting in an estimated 60,000 deaths, while vaccination is a cost-effective and secure preventive measure to combat this disease, the current killed vaccine only provides short-term immunity specific to certain strains of the zoonotic disease, say scientists

​One million cases of human leptospirosis are reported every year resulting in an estimated 60,000 deaths, while vaccination is a cost-effective and secure preventive measure to combat this disease, the current killed vaccine only provides short-term immunity specific to certain strains of the zoonotic disease, say scientists